FDA Inspection
Charles Eubank, Jr. M.D.Charles Eubank, Jr. M.D. – FDA Inspection, Sep 14, 2012
Record Details
This FDA Inspection record concerns Charles Eubank, Jr. M.D., with an inspection on September 14, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Charles Eubank, Jr. M.D.
- Inspection Date
- September 14, 2012
- Product Type
- Drugs
View Company Profile
ID · 05ca5d76-0cd0-4386-aa2b-0fe42ab915d0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 797316
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Charles Eubank, Jr. M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Charles Eubank, Jr. M.D.
- FDA Inspection 1075122 - 2018-11-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.